The prevalence of antibodies to hepatitis E virus (anti-HEV) was investigated in patients with acute hepatitis, and correlated with the clinical featu res.
Sera from 110 patients with acute hepatitis and 60 healthy controls were tested for anti-HEV, antibody to hepatitis C virus (antiHCV), and hepatitis B surface antigen (HBsAg).
There were significant differences in the prevalence of anti-HEV, anti-HCV, and HBsAg between patients and controls (21.8% vs. 0%, 16.3% vs. 1.6% and 58.1% vs. 18.0%, respectively).
AntiHEV was detected in 6 (25.0%) of 24 patients with anti-HCV, 6 (9.3%) of 64 patients with HBsAg, and another 6 (22.2%) of 27 patients with acute hepatitis non-A, non-B, non-C.
Mots-clés Pascal : Virus hépatite E, Virus, Anticorps, Prévalence, Epidémiologie, Homme, Taiwan, Asie, Aigu, Hépatite virale, Virose, Infection, Appareil digestif pathologie, Foie pathologie
Mots-clés Pascal anglais : Hepatitis E virus, Virus, Antibody, Prevalence, Epidemiology, Human, Taiwan, Asia, Acute, Viral hepatitis, Viral disease, Infection, Digestive diseases, Hepatic disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0676079
Code Inist : 002B05C02G. Création : 09/06/1995.